© 2006 European Society for Medical Oncology
symposium article |
Challenges in the treatment of gastrointestinal tumours
1 Department of Oncology, Ospedali Riuniti, Bergamo, Italy; 2 Department of Oncology, Ospedale Civile, Sondrio, Italy
* Correspondence to: Dr R. Labianca, Department of Oncology, Ospedali Riuniti, L.go Barozzi, 1, 24128 Bergamo Italy. Tel: +39 035 269724; Fax: +39 035 266849; E-mail: segroncologia{at}ospedaliriuniti.bergamo.it
In the last 20 years there have been many breakthroughs in the treatment of gastrointestinal tumours. In this review we have considered the three most important subgroups of gastrointestinal tumours (colorectal, gastric and pancreatic cancer), focusing on the state-of-the-art treatments.
Key words: gastrointestinal tumours, colorectal, gastric and pancreatic cancer, monoclonal antibodies, target therapies, prognostic factors